CASE REPORT
Accepted on 20 Jan 2025
Bevacizumab-induced cerebrovascular events: a case series report and literature review
doi 10.3389/fonc.2025.1395129
- Frontiers in Oncology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Safety consideration in the development of anti-tumor monoclonal antibodies during drug development
Safety consideration in the development of anti-tumor monoclonal antibodies during drug development
4,600
Total downloads
13k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 21 Aug 2024
Comparative analysis of adverse event risks in breast cancer patients receiving pembrolizumab combined with paclitaxel versus paclitaxel monotherapy: insights from the FAERS database
doi 10.3389/fphar.2024.1345671
- 989 views
ORIGINAL RESEARCH
Published on 08 Aug 2024
In silico evaluation of the role of Fab glycosylation in cetuximab antibody dynamics
doi 10.3389/fimmu.2024.1429600
- 1,737 views
ORIGINAL RESEARCH
Published on 23 Jul 2024
A two-stage maintenance trial of cetuximab-based treatment in RAS and BRAF wild-type unresectable metastatic colorectal cancer: a retrospective real-world study
doi 10.3389/fonc.2024.1425203
- 870 views
ORIGINAL RESEARCH
Published on 25 Jun 2024
A real-world pharmacovigilance study of polatuzumab vedotin based on the FDA adverse event reporting system (FAERS)
doi 10.3389/fphar.2024.1405023
- 1,660 views
- 1 citation
REVIEW
Published on 30 Apr 2024
Regulatory considerations in the design, development and quality of monoclonal antibodies and related products for the diagnosis and treatment of cancer
doi 10.3389/fonc.2024.1379738
- 2,950 views
- 5 citations
ORIGINAL RESEARCH
Published on 05 May 2023
Novel infusion strategy reduces severe adverse events caused by the anti-GD2 monoclonal antibody naxitamab
doi 10.3389/fonc.2023.1164949
- 2,656 views
- 4 citations
Published in
Frontiers in Oncology
- Pharmacology of Anti-Cancer Drugs
Participating Journals
Frontiers in Pharmacology
- 4.4 impact factor
- 7.8 citescore
Impact
- 13kTopic views
- 8,664Article views
- 4,600Article downloads